Inhibition of GPX4 induces the death of p53-mutant triple-negative breast cancer cells

Related articles

1. The small molecule inhibitor SU056-mediated targeting of YB1 inhibits the Rb pathway in triple negative breast cancer tumors

   This article has 7 authors:

   1. Wei Wang
   2. Yeaji Kim
   3. Xiaotong Zhao
   4. Kristen Weber Bonk
   5. Ruth Keri
   6. Bin Su
   7. Khalid Sossey-Alaoui

2. Targeting Polθ Helicase with RP-3467: Preclinical Validation and Clinical Response in a g BRCA1 ovarian cancer patient with an acquired PARPi resistance mutation in TP53BP1

   This article has 32 authors:

   1. Ezra Y. Rosen
   2. Marie-Claude Mathieu
   3. Gino B. Ferraro
   4. Philippe Mochirian
   5. Claude Godbout
   6. Hugo Poirier
   7. Sara Fournier
   8. Danielle Henry
   9. Hyeyeon Kim
   10. Robert Papp
   11. Shou Yun Yin
   12. Marie-Eve Leclaire
   13. Robert Houle
   14. Parham Nejad
   15. Joseph D. Schonhoft
   16. Karl E. Zahn
   17. W. Cameron Black
   18. Michel Gallant
   19. Insil Kim
   20. Danielle Ulanet
   21. Paul Basciano
   22. Artur Veloso
   23. Victoria Rimkunas
   24. Timothy A. Yap
   25. Robin Guo
   26. Nicholas Mai
   27. Maria Koehler
   28. Michael Zinda
   29. Anne Roulston
   30. Michal Zimmermann
   31. Stephen J. Morris
   32. Agnel Sfeir

3. Dual inhibition of p38α MAPK and Casein kinase δ/ε as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer

   This article has 10 authors:

   1. Sayak Chakravarti
   2. Suman Mazumder
   3. Farnaz Hemmati
   4. Farshad Amiri
   5. Sarah Batten
   6. Panagiotis Mistriotis
   7. Robert Rusty Arnold
   8. Ujjal Kumar Mukherjee
   9. Taraswi Mitra Ghosh
   10. Amit Kumar Mitra